Assessment of a non-physician screening program for hypertension and cardiovascular risk in community pharmacies

Pappaccogli, Marco; Enri, Lorenzo Ravetto; Perlo, E.; Monaco, Silvia Di; Pignata, Irene; Baratta, Francesca; Rabbia, Franco; Mana, Massimo; Veglio, Franco; Brusa, Paola

doi:10.1016/j.numecd.2019.07.009

Cited by 9 publications

(7 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The digital BP monitors used within the services need to be of good quality (validated for clinical use15–18) and need regular maintenance (calibration) for accurate functioning. This phenomenon has been well studied in physicians’ offices,19–21 but less so in pharmacy settings 22–24…”

Section: Introductionmentioning

confidence: 99%

Quality evaluation of community pharmacy blood pressure (BP) screening services: an English cross-sectional survey with geospatial analysis

Barrett

Hodgkinson

2019

BMJ Open

View full text Add to dashboard Cite

ObjectivesThe primary objective was to assess the accuracy (calibration and validation status) of digital blood pressure (BP) monitors used within community pharmacy in England and the secondary objectives were to assess the overall quality of the BP service by assessing service prevalence, service utilisation and other in-service considerations.DesignA cross-sectional survey.SettingPrimary-care retail-pharmacies.Participants500 pharmacies that contribute to government dispensing-data were invited by post to complete the survey. Private contractors were excluded.InterventionsWe conducted a questionnaire survey with a follow-up (September 2018 to December 2018).Results109 responses were received. 61% (n=66) of responding pharmacies provided a free BP check to their patients. 40 (61%) pharmacies used recommended validated clinical metres, 6 (9%) had failed validation and 20 (30%) provided too little information to enable us to determine their monitor’s status.ConclusionsResponding pharmacies were able to provide useful BP monitoring services to their patients, though quality enhancements need to be implemented. Majority of pharmacies use validated BP monitors, however, there was a lack of range of cuff sizes, variation in replacement and calibration of monitors and apparent absence of such practice in a minority of pharmacies alongside variation in training standards. We noted higher frequency of BP screening in the most deprived postcodes.We recommend in-service redesign and delivery improvements, and suggest professional bodies and researchers work together to create clearer frameworks for front-line practitioners, creating appropriate incentives to facilitate this service redesign.Funders and policy setters should consider the value added to the National Health Service and other healthcare agencies of such screening by pharmacy providers both nationally and internationally. It has the potential to reduce complications of undiagnosed hypertension and the medicines burden that it creates. Future work should examine the impact of pharmacist-led BP screening on patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Quality evaluation of community pharmacy blood pressure (BP) screening services: an English cross-sectional survey with geospatial analysis

Barrett

Hodgkinson

2019

BMJ Open

View full text Add to dashboard Cite

show abstract

“…Patients are supportive of screening by their pharmacist, improving awareness on their BP status, 24‐26 and if referred, a median of 44% received a new hypertension diagnosis or antihypertensive medication 21 …”

Section: Discussionmentioning

confidence: 99%

Development and implementation of blood pressure screening and referral guidelines for German community pharmacists

Schulz

Griese‐Mammen

Schumacher

et al. 2020

J of Clinical Hypertension

View full text Add to dashboard Cite

show abstract

“…The range of services provided by community pharmacists in Italy has grown considerably over the last two decades [18] , [19] , [20] , [21] , [22] , [23] . This has brought with it greater responsibility and added duties.…”

Section: Introductionmentioning

confidence: 99%

Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic

2023

Self Cite

View full text Add to dashboard Cite

Assessment of a non-physician screening program for hypertension and cardiovascular risk in community pharmacies

Cited by 9 publications

References 18 publications

Quality evaluation of community pharmacy blood pressure (BP) screening services: an English cross-sectional survey with geospatial analysis

Quality evaluation of community pharmacy blood pressure (BP) screening services: an English cross-sectional survey with geospatial analysis

Development and implementation of blood pressure screening and referral guidelines for German community pharmacists

Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic

Contact Info

Product

Resources

About